Tag: biosynthetic cannabinoids

Colossally Cool Cannabinoids Captivate Creo, Genomatica, Amyris, others

Colossally Cool Cannabinoids Captivate Creo, Genomatica, Amyris, others

February 14, 2021 |

Last week the focus was on hot hemp and this week it’s cool cannabinoids. From California’s Creo becoming the first company to achieve demo scale production of rare cannabinoid CBGA in partnership with Genomatica, to Amyris’s expansion of consumer brands by launching a new range of Terasana products using cannabinoids, we dive into what is […]

Read More

Amyris responds to LAVVAN’s lawsuit filing, clarifies 3 points

Amyris responds to LAVVAN’s lawsuit filing, clarifies 3 points

September 13, 2020 |

In California, Amyris, Inc. responds to LAVVAN, Inc.’s press release related to its commencement of a lawsuit against Amyris for patent infringement and trade secret misappropriation and submitted this statement to clarify several points. Amyris and LAVVAN entered into a Research, Collaboration and License Agreement in March 2019 valued at $300 million in milestone payments […]

Read More